Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT07858968

Pelvic Floor Rehabilitation Programme for Women With Urinary Incontinence in a Peruvian Public Hospital

Conditions: Urinary Incontinence, Urinary Incontinence, Stress, Urinary Incontinence, Urge, Mixed Urinary Incontinence

Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 89
Sponsor: Hospital Nacional Edgardo Rebagliati Martins

Location: Hospital Nacional Edgardo Rebagliati Martins Lima Lima Province

Summary

This study evaluates whether a 12-week pelvic floor rehabilitation programme improves urinary incontinence symptoms in adult women treated at Hospital Nacional Edgardo Rebagliati Martins, a public tertiary hospital in Lima, Peru. Women referred by the Urology Service attend supervised group pelvic floor muscle training with a physiotherapist, together with individual sessions with a physiatrist that may include EMG biofeedback, electrical stimulation, transcutaneous tibial nerve stimulation, myofascial techniques or bladder training. The main question is whether symptom severity, measured with the ICIQ-SF questionnaire, improves between baseline and week 12. Participants are followed for 6 months.

Eligibility Criteria

Inclusion Criteria: * Women aged 18 years or older, insured by EsSalud and treated at Hospital Nacional Edgardo Rebagliati Martins * Urinary incontinence diagnosed by the Urology Service of the hospital * Signed informed consent Exclusion Criteria: * Current pregnancy * Urinary incontinence of documented neurological cause * Pelvic organ prolapse stage II or higher (POP-Q) * Severe cognitive impairment preventing active participation or completion of questionnaires * Refusal to sign informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07858968). StuddyBuddy aggregates publicly available trial information.